The City College of New York was recognized on May 6 as one of the top universities in the United States for its ability to translate scientific discovery into real-world healthcare impact, according to the inaugural Cure Innovation Index. The college ranks #162 among 243 universities evaluated nationwide and is also acknowledged as a Leading Hispanic Serving Institution.
The ranking highlights the importance of how research institutions move scientific breakthroughs from the laboratory to practical applications that improve health outcomes. The Cure Innovation Index is described as “the first national, data-driven platform designed to assess how effectively U.S. biomedical research institutions convert discovery into therapies, companies, and measurable health outcomes.” In addition to its overall ranking, City College placed #135 for market translation, #150 for entrepreneurial readiness, and #217 for research capabilities.
“This ranking highlights our commitment to scientific research that makes people’s lives better. We work on problems that make a difference in the world,” said Dr. Tony Liss, CCNY Provost and Senior Vice President for Academic Affairs.
Seema Kumar, CEO of Cure, said: “Recognition of The City College of New York in the Cure Innovation Index reflects its leadership in translating scientific discovery into real-world impact. While traditional measures emphasize funding, publications, or patents, the Index sets a new standard by evaluating the full set of capabilities required to move innovation from concept to cure.”
The index evaluates institutions across three core domains: research capabilities, entrepreneurial readiness, and market translation. It uses data from federal and commercial sources along with proprietary surveys and institutional audits.
Looking ahead, CCNY’s recognition signals continued efforts toward advancing innovations beyond academic settings into therapies and products that address public health needs.
